加科思-B(01167)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01167 加科思-B

已收盘 05-03 16:09:00

1.860

-0.100

-5.10%

最高2.000	最低1.850	成交量92.49万
今开1.960	昨收1.960	日振幅7.65%
总市值14.73亿	流通市值14.73亿	总股本7.92亿
成交额175.07万	换手率0.12%	流通股本7.92亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01167","market":"HK","secType":"STK","nameCN":"加科思-B","latestPrice":1.86,"timestamp":1714723740027,"preClose":1.96,"halted":0,"volume":924900,"delay":0,"floatShares":791755080,"shares":791755080,"eps":-0.50446177,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.1,"latestTime":"05-03 16:09:00","open":1.96,"high":2,"low":1.85,"amount":1750668,"amplitude":0.076531,"askPrice":1.88,"askSize":3300,"bidPrice":1.86,"bidSize":56700,"shortable":0,"etf":0,"ttmEps":-0.5044617580505263,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714959000000},"adr":0,"listingDate":1608480000000,"adjPreClose":1.96,"openAndCloseTimeList":[[1714699800000,1714708800000],[1714712400000,1714723200000]],"volumeRatio":0.960316,"lotSize":300,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01167/wiki","defaultTab":"wiki","newsList":[{"id":"2432192941","title":"加科思-B(01167)下跌5.1%，报1.86元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2432192941","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2432192941?lang=zh_cn&edition=full","pubTime":"2024-05-03 15:37","pubTimestamp":1714721834,"startTime":"0","endTime":"0","summary":"5月3日，加科思-B(01167)盘中下跌5.1%，截至15:37，报1.86元/股，成交170.81万元。加科思药业集团有限公司是一家专注于临床阶段新药研发，特别是创新肿瘤疗法的自主发现和开发的中国投资控股公司。其主要药物开发项目包括JAB-3068及JAB-3312临床阶段的变构SHP2抑制剂，并主要在国内市场开展业务。截至2023年年报，加科思-B营业总收入6352.0万元、净利润-3.59亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/05/03153740514419.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2432899460","title":"加科思-B盘中异动 早盘急速下挫5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432899460","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432899460?lang=zh_cn&edition=full","pubTime":"2024-05-03 10:22","pubTimestamp":1714702932,"startTime":"0","endTime":"0","summary":"2024年05月03日早盘10时22分，加科思-B股票出现波动，股价大幅下跌5.05%。截至发稿，该股报1.861港元/股，成交量37.83万股，换手率0.05%，振幅7.14%。加科思-B股票所在的生物技术行业中，整体跌幅为0.62%。其相关个股中，美因基因、和铂医药-B、科笛-B涨幅较大，振幅较大的相关个股有圣诺医药-B、药明合联、美因基因，振幅分别为16.55%、13.02%、12.83%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503102212861eac62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503102212861eac62&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432643377","title":"港股异动 | 基石药业-B(02616)涨超26%领涨创新药概念 ASCO催化行情 机构看好政策+医保边际向上","url":"https://stock-news.laohu8.com/highlight/detail?id=2432643377","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2432643377?lang=zh_cn&edition=full","pubTime":"2024-05-02 13:56","pubTimestamp":1714629376,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，创新药概念股表现强势，截至发稿，基石药业-B涨26.14%，报1.11港元；康希诺生物涨16.91%，报20.95港元；加科思-B涨14.2%，报1.93港元；诺诚健华涨12.31%，报5.2港元；荣昌生物涨10.2%，报30.8港元。浙商证券指出，2023年创新药医保谈判结果高成功率及温和降幅，体现出政策对创新药倾斜与支持，我们期待更多的创新药行业规范化以及支持的政策推进。创新药已形成较为稳定的谈判节奏和价格预期，我们持续看好创新药行业中长期的投资机会。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1116861.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2432869792","title":"迈博药业-B盘中异动 大幅下跌8.98%报0.365港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432869792","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432869792?lang=zh_cn&edition=full","pubTime":"2024-05-02 11:04","pubTimestamp":1714619055,"startTime":"0","endTime":"0","summary":"2024年05月02日早盘11时04分，迈博药业-B股票出现异动，股价大幅跳水8.98%。截至发稿，该股报0.365港元/股，成交量0股，换手率0.00%，振幅0.00%。迈博药业-B股票所在的生物技术行业中，整体涨幅为0.85%。其相关个股中，加科思-B、康希诺生物、基石药业-B涨幅较大，振幅较大的相关个股有加科思-B、基石药业-B、科笛-B，振幅分别为14.20%、11.36%、11.34%。该公司主要在中国境内经营业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405021104157a57e5b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405021104157a57e5b5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432695871","title":"加科思-B盘中异动 股价大涨5.33%报1.780港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432695871","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432695871?lang=zh_cn&edition=full","pubTime":"2024-05-02 09:52","pubTimestamp":1714614724,"startTime":"0","endTime":"0","summary":"2024年05月02日早盘09时52分，加科思-B股票出现异动，股价急速拉升5.33%。截至发稿，该股报1.780港元/股，成交量6.84万股，换手率0.01%，振幅5.92%。资金方面，该股资金流入8.1015万港元，流出3.1941万港元。加科思-B股票所在的生物技术行业中，整体跌幅为0.27%。其相关个股中，科笛-B、北海康成-B、加科思-B涨幅较大，振幅较大的相关个股有科笛-B、创胜集团-B、基石药业-B，振幅分别为6.69%、6.08%、5.68%。公司主要药物开发项目包括JAB-3068及JAB-3312临床阶段的变构SHP2抑制剂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050209520587e85424&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050209520587e85424&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432545695","title":"加科思－Ｂ(01167)股价上升5.325%，现价港币$1.78","url":"https://stock-news.laohu8.com/highlight/detail?id=2432545695","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2432545695?lang=zh_cn&edition=full","pubTime":"2024-05-02 09:40","pubTimestamp":1714614000,"startTime":"0","endTime":"0","summary":"[上升股]加科思－Ｂ(01167) 股价在上午09:40比前收市价上升5.325%，现股价为港币$1.78。至目前为止，今日最高价为$1.78，而最低价为$1.7。总成交量为2.58万股，总成交金额为港币$4.538万。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR240502281/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2431502693","title":"加科思-B(01167)上涨7.69%，报1.82元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2431502693","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2431502693?lang=zh_cn&edition=full","pubTime":"2024-04-29 10:57","pubTimestamp":1714359476,"startTime":"0","endTime":"0","summary":"4月29日，加科思-B(01167)盘中上涨7.69%，截至10:57，报1.82元/股，成交104.07万元。加科思药业集团有限公司是一家专注于临床阶段新药研发，特别是创新肿瘤疗法的自主发现和开发的中国投资控股公司。其主要药物开发项目包括JAB-3068及JAB-3312临床阶段的变构SHP2抑制剂，并主要在国内市场开展业务。截至2023年年报，加科思-B营业总收入6352.0万元、净利润-3.59亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/29105740460553.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431025270","title":"加科思-B盘中异动 早盘股价大涨5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431025270","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431025270?lang=zh_cn&edition=full","pubTime":"2024-04-29 10:27","pubTimestamp":1714357661,"startTime":"0","endTime":"0","summary":"2024年04月29日早盘10时27分，加科思-B股票出现波动，股价大幅上涨5.33%。截至发稿，该股报1.780港元/股，成交量38.55万股，换手率0.05%，振幅5.33%。加科思-B股票所在的生物技术行业中，整体涨幅为1.23%。其相关个股中，乐普生物-B、欧康维视生物-B、金斯瑞生物科技涨幅较大，振幅较大的相关个股有来凯医药-B、宜明昂科-B、科笛-B，振幅分别为11.49%、9.40%、9.29%。公司主要药物开发项目包括JAB-3068及JAB-3312临床阶段的变构SHP2抑制剂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042910274187e848cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042910274187e848cc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430621061","title":"加科思-B(01167)上涨5.0%，报1.68元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2430621061","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2430621061?lang=zh_cn&edition=full","pubTime":"2024-04-26 14:56","pubTimestamp":1714114583,"startTime":"0","endTime":"0","summary":"4月26日，加科思-B(01167)盘中上涨5.0%，截至14:56，报1.68元/股，成交104.06万元。加科思药业集团有限公司是一家专注于临床阶段新药研发，特别是创新肿瘤疗法的自主发现和开发的中国投资控股公司。其主要药物开发项目包括JAB-3068及JAB-3312临床阶段的变构SHP2抑制剂，并主要在国内市场开展业务。截至2023年年报，加科思-B营业总收入6352.0万元、净利润-3.59亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/26145640426932.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430588211","title":"加科思-B盘中异动 大幅拉升5.56%报1.690港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430588211","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430588211?lang=zh_cn&edition=full","pubTime":"2024-04-26 13:48","pubTimestamp":1714110496,"startTime":"0","endTime":"0","summary":"2024年04月26日下午盘13时48分，加科思-B股票出现异动，股价大幅拉升5.56%。截至发稿，该股报1.690港元/股，成交量42.6万股，换手率0.05%，振幅6.87%。资金方面，该股资金流入39.1689万港元，流出28.2933万港元。机构评级方面，在所有1家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。其相关个股中，帝王国际投资、科伦博泰生物-B、绿竹生物-B涨幅较大，振幅较大的相关个股有泰格医药、永泰生物-B、君实生物，振幅分别为11.13%、10.68%、10.55%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240426134816861e9756&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240426134816861e9756&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430423560","title":"加科思-B盘中异动 下午盘股价大涨5.33%报1.601港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430423560","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430423560?lang=zh_cn&edition=full","pubTime":"2024-04-25 14:20","pubTimestamp":1714026042,"startTime":"0","endTime":"0","summary":"2024年04月25日下午盘14时20分，加科思-B股票出现波动，股价急速上涨5.33%。截至发稿，该股报1.601港元/股，成交量30.24万股，换手率0.04%，振幅7.89%。资金方面，该股资金流入32.2173万港元，流出13.0854万港元。加科思-B股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，维亚生物、腾盛博药-B、乐普生物-B涨幅较大，振幅较大的相关个股有腾盛博药-B、科济药业-B、来凯医药-B，振幅分别为17.00%、16.04%、15.76%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425142042861e8d7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425142042861e8d7f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430449370","title":"加科思－Ｂ(01167)股价上升5.263%，现价港币$1.6","url":"https://stock-news.laohu8.com/highlight/detail?id=2430449370","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2430449370?lang=zh_cn&edition=full","pubTime":"2024-04-25 11:53","pubTimestamp":1714017180,"startTime":"0","endTime":"0","summary":"[上升股]加科思－Ｂ(01167) 股价在上午11:53比前收市价上升5.263%，现股价为港币$1.6。至目前为止，今日最高价为$1.6，而最低价为$1.48。总成交量为20.67万股，总成交金额为港币$31.6万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2404252280/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2429454038","title":"加科思-B(01167)建议委任德勤为独立核数师","url":"https://stock-news.laohu8.com/highlight/detail?id=2429454038","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429454038?lang=zh_cn&edition=full","pubTime":"2024-04-24 22:29","pubTimestamp":1713968976,"startTime":"0","endTime":"0","summary":"智通财经APP讯，加科思-B(01167)发布公告，罗兵咸永道会计师事务所将于公司预期于2024年6月7日举行的应届股东周年大会结束时任期届满并退任公司核数师之职，董事会根据公司审核委员会之推荐意见，已决议不再续聘罗兵咸永道为公司核数师。根据公司之组织章程细则以及经公司审核委员会推荐，董事会已议决建议委任德勤•关黄陈方会计师行为公司独立核数师，自股东周年大会结束起生效，直至公司下届股东周年大会结束后为止，惟须待股东于股东周年大会上以普通决议案批准，方可作实。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1109361.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429137469","title":"加科思-B盘中异动 股价大涨6.16%报1.550港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429137469","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429137469?lang=zh_cn&edition=full","pubTime":"2024-04-23 13:12","pubTimestamp":1713849176,"startTime":"0","endTime":"0","summary":"2024年04月23日下午盘13时12分，加科思-B股票出现异动，股价快速上涨6.16%。截至发稿，该股报1.550港元/股，成交量16.59万股，换手率0.02%，振幅8.90%。资金方面，该股资金流入11.0679万港元，流出10.3731万港元。加科思-B股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，北海康成-B、康诺亚-B、来凯医药-B涨幅较大，振幅较大的相关个股有北海康成-B、药明合联、来凯医药-B，振幅分别为31.25%、10.14%、10.11%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423131257792281fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423131257792281fb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429130354","title":"加科思－Ｂ(01167)股价上升6.164%，现价港币$1.55","url":"https://stock-news.laohu8.com/highlight/detail?id=2429130354","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2429130354?lang=zh_cn&edition=full","pubTime":"2024-04-23 13:12","pubTimestamp":1713849120,"startTime":"0","endTime":"0","summary":"[上升股]加科思－Ｂ(01167) 股价在下午01:12比前收市价上升6.164%，现股价为港币$1.55。至目前为止，今日最高价为$1.55，而最低价为$1.42。总成交量为16.59万股，总成交金额为港币$23.994万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180126133719348_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180126133719348_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2404232428/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2428282572","title":"加科思-B盘中异动 快速下跌5.26%报1.440港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428282572","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428282572?lang=zh_cn&edition=full","pubTime":"2024-04-19 10:20","pubTimestamp":1713493257,"startTime":"0","endTime":"0","summary":"2024年04月19日早盘10时20分，加科思-B股票出现异动，股价急速下挫5.26%。截至发稿，该股报1.440港元/股，成交量7.56万股，换手率0.01%，振幅3.95%。资金方面，该股资金流入4380港元，流出8.8488万港元。加科思-B股票所在的生物技术行业中，整体跌幅为0.76%。其相关个股中，创胜集团-B、帝王国际投资、三叶草生物-B涨幅较大，振幅较大的相关个股有三叶草生物-B、创胜集团-B、乐普生物-B，振幅分别为12.70%、12.50%、9.30%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404191020577921b2c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404191020577921b2c8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428957749","title":"加科思－Ｂ(01167)股价下跌5.263%，现价港币$1.44","url":"https://stock-news.laohu8.com/highlight/detail?id=2428957749","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2428957749?lang=zh_cn&edition=full","pubTime":"2024-04-19 10:20","pubTimestamp":1713493200,"startTime":"0","endTime":"0","summary":"[下跌股]加科思－Ｂ(01167) 股价在上午10:20比前收市价下跌5.263%，现股价为港币$1.44。至目前为止，今日最高价为$1.5，而最低价为$1.44。总成交量为7.26万股，总成交金额为港币$10.638万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2404192014/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2428407588","title":"加科思-B盘中异动 急速上涨6.07%报1.591港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428407588","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428407588?lang=zh_cn&edition=full","pubTime":"2024-04-18 09:30","pubTimestamp":1713403859,"startTime":"0","endTime":"0","summary":"2024年04月18日早盘09时30分，加科思-B股票出现波动，股价急速拉升6.07%。截至发稿，该股报1.591港元/股，成交量1.02万股，换手率0.00%，振幅0.00%。资金方面，该股资金流入1.6218万港元，流出0港元。加科思-B股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，加科思-B、3D MEDICINES、瑞科生物-B涨幅较大，振幅较大的相关个股有圣诺医药-B、康方生物、泰格医药，振幅分别为2.09%、1.71%、1.62%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418093059861e6cba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418093059861e6cba&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428885095","title":"加科思－Ｂ(01167)股价上升6%，现价港币$1.59","url":"https://stock-news.laohu8.com/highlight/detail?id=2428885095","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2428885095?lang=zh_cn&edition=full","pubTime":"2024-04-18 09:30","pubTimestamp":1713403800,"startTime":"0","endTime":"0","summary":"[上升股]加科思－Ｂ(01167) 股价在上午09:30比前收市价上升6%，现股价为港币$1.59。至目前为止，今日最高价为$1.59，而最低价为$1.59。总成交量为1.02万股，总成交金额为港币$1.622万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR24041837/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2427902358","title":"加科思-B盘中异动 下午盘急速下挫5.09%报1.510港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427902358","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427902358?lang=zh_cn&edition=full","pubTime":"2024-04-16 14:40","pubTimestamp":1713249658,"startTime":"0","endTime":"0","summary":"2024年04月16日下午盘14时40分，加科思-B股票出现波动，股价快速下挫5.09%。截至发稿，该股报1.510港元/股，成交量35.64万股，换手率0.05%，振幅6.92%。资金方面，该股资金流入14.304万港元，流出38.6052万港元。机构评级方面，在所有2家参与评级的机构中，50%的券商给予买入建议，50%的券商给予持有建议，无券商给予卖出建议。加科思-B股票所在的生物技术行业中，整体跌幅为1.22%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161440597a5310d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161440597a5310d0&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jacobiopharma.com","stockEarnings":[{"period":"1week","weight":0.225},{"period":"1month","weight":0.1879},{"period":"3month","weight":-0.2222},{"period":"6month","weight":-0.5},{"period":"1year","weight":-0.7021},{"period":"ytd","weight":-0.4586}],"compareEarnings":[{"period":"1week","weight":0.0534},{"period":"1month","weight":0.0753},{"period":"3month","weight":0.1721},{"period":"6month","weight":0.0307},{"period":"1year","weight":-0.0757},{"period":"ytd","weight":0.068}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"加科思药业集团有限公司是一家主要从事临床阶段新药研发的中国投资控股公司。该公司主要负责创新肿瘤疗法的自主发现和开发。公司主要药物开发项目包括JAB-3068及JAB-3312临床阶段的变构SHP2抑制剂。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.005532},{"month":2,"riseRate":0.25,"avgChangeRate":0.053851},{"month":3,"riseRate":0,"avgChangeRate":-0.187604},{"month":4,"riseRate":0.75,"avgChangeRate":0.048427},{"month":5,"riseRate":0.5,"avgChangeRate":0.015074},{"month":6,"riseRate":0,"avgChangeRate":-0.051806},{"month":7,"riseRate":0,"avgChangeRate":-0.217279},{"month":8,"riseRate":0.333333,"avgChangeRate":0.025412},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.12321},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.013633},{"month":11,"riseRate":0.333333,"avgChangeRate":0.071626},{"month":12,"riseRate":0.333333,"avgChangeRate":0.002401}],"exchange":"SEHK","name":"加科思-B","nameEN":"JACOBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"加科思-B(01167)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供加科思-B(01167)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"加科思-B,01167,加科思-B股票,加科思-B股票老虎,加科思-B股票老虎国际,加科思-B行情,加科思-B股票行情,加科思-B股价,加科思-B股市,加科思-B股票价格,加科思-B股票交易,加科思-B股票购买,加科思-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"加科思-B(01167)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供加科思-B(01167)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}